SynthesisMultiple sclerosis and related disorders2022

Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies.

Tyler E Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.